Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates

Konstantinos Douroudis, Antti Pekka Laine, Mirkka Heinonen, Robert Hermann, Kati Lipponen, Riitta Veijola, Olli Simell, Mikael Knip, Raivo Uibo, Jorma Ilonen, Kalle Kisand*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)

Abstract

Cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and inducible T-cell co-stimulator (ICOS) genes are important mediators of T-cell activation in autoimmune diseases. The aim of the current study was to assess the impact of CTLA-4 and ICOS genes on the susceptibility to type 1 diabetes among two populations with different disease incidence rates. Three single nucleotide polymorphisms (SNPs) within the CTLA-4 region (+49A/G, CT60A/G, CTBC217_1C/T) and two SNPs within the ICOS region (CTIC154_1 C/T, CTIC159 C/G) were genotyped in 955 control subjects and 574 diabetic patients of Estonian and Finnish descent. The current study confirms the involvement of the CTLA-4 but not the ICOS gene in susceptibility to type 1 diabetes. However, the risk alleles and the defined main risk haplotype were more common in the Finnish controls compared with the Estonians, indicating that this gene locus might also be one of the contributing factors to the higher disease incidence in Finland.

Original languageEnglish
Pages (from-to)536-539
Number of pages4
JournalHuman Immunology
Volume70
Issue number7
DOIs
Publication statusPublished - Jul 2009
Externally publishedYes

Keywords

  • CTLA-4
  • ICOS
  • Type 1 diabetes

Fingerprint

Dive into the research topics of 'Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates'. Together they form a unique fingerprint.

Cite this